🇺🇸 Monovalent HBV vaccine in United States

Monovalent HBV vaccine (Monovalent HBV vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Monovalent HBV vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Monovalent HBV vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Monovalent HBV vaccine in United States?

University of North Carolina, Chapel Hill is the originator. The local marketing authorisation holder may differ — check the official source linked above.